Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other
companies in this sector in Japan:
Eisai Company Limited
sales of 539.10 billion Japanese Yen [US$4.82 billion]
Shionogi & Co Ltd
(338.89 billion Japanese Yen [US$3.03 billion]
Taisho Pharmaceutical Holdings Co Ltd
(279.77 billion Japanese Yen [US$2.50 billion]
During the year ended March of 2017, sales at
Mitsubishi Tanabe Pharma Corp were ¥423.98 billion (US$3.79 billion).
decrease of 1.8%
versus 2016, when the company's sales were ¥431.70 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Mitsubishi Tanabe Pharma Corp had sales
of ¥407.16 billion.